|
1
|
Chen Y, Liu C, Xie B, Chen S, Zhuang Y and
Zhang S: miR96 exerts an oncogenic role in the progression of
cervical cancer by targeting CAV1. Mol Med Rep. 22:543–550.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Global Burden of Disease Cancer
Collaboration. Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
alThe global burden of cancer 2013. JAMA Oncol. 4:505–527.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wei KR, Chen WQ, Zhang SW, Zheng RS, Wang
YN and Liang ZH: Epidemiology of uterine corpus cancer in some
cancer registering areas of China from 2003-2007. Zhonghua Fu Chan
Ke Za Zhi. 6:445–451. 2012.PubMed/NCBI(In Chinese).
|
|
4
|
Sousa DMDN, Chagas ACMA, Vasconcelos CTM,
Stein AT and Oriá MOB: Development of a clinical protocol for
detection of cervical cancer precursor lesions. Rev Lat Am
Enfermagem. 26(e2999)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
McClung NM, Gargano JW, Park IU, Whitney
E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM,
Brackney M, et al: Estimated number of cases of high-grade cervical
lesions diagnosed among women-United States, 2008 and 2016. MMWR
Morb Mortal Wkly Rep. 68:337–343. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Su M, Gong XJ and Zhou X: Research
progress in mechanism of traditional Chinese medicine active
ingredients against cervical cancer. Zhongguo Zhong Yao Za Zhi.
44:675–684. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
7
|
Yang J, Li J, Sun M and Chen K: Studies of
traditional Chinese medicine monomer on HeLa cell of cervical
cancer. Pak J Pharm Sci. 27 (4 Suppl):S1063–S1068. 2014.PubMed/NCBI
|
|
8
|
Zhu J, Chen Z, Lallemand-Breitenbach V and
de Thé H: How acute promyelocytic leukaemia revived arsenic. Nat
Rev Cancer. 2:705–713. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM,
Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al: Use of arsenic
trioxide (As2O3) in the treatment of acute promyelocytic leukemia
(APL): II. Clinical efficacy and pharmacokinetics in relapsed
patients. Blood. 89:3354–3360. 1997.PubMed/NCBI
|
|
10
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kozono S, Lin YM, Seo HS, Pinch B, Lian X,
Qiu C, Herbert MK, Chen CH, Tan L, Gao ZJ, et al: Arsenic targets
Pin1 and cooperates with retinoic acid to inhibit cancer-driving
pathways and tumor-initiating cells. Nat Commun.
9(3069)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sadaf N, Kumar N, Ali M, Ali V, Bimal S
and Haque R: Arsenic trioxide induces apoptosis and inhibits the
growth of human liver cancer cells. Life Sci. 205:9–17.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu B, Tan M, Cai W, Wang B, He P and Zhang
X: Arsenic trioxide induces autophagic cell death in osteosarcoma
cells via the ROS-TFEB signaling pathway. Biochem Biophys Res
Commun. 1:167–175. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang H, Gao P and Zheng J: Arsenic
trioxide inhibits cell proliferation and human papillomavirus
oncogene expression in cervical cancer cells. Biochem Biophys Res
Commun. 441:556–561. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jambunathan N: Determination and detection
of reactive oxygen species (ROS), lipid peroxidation, and
electrolyte leakage in plants. Methods Mol Biol. 639:292–298.
2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang G, Li Y, Yang Z, Xu W, Yang Y and Tan
X: ROS mediated EGFR/MEK/ERK/HIF-1α loop regulates glucose
metabolism in pancreatic cancer. Biochem Biophys Res Commun.
500:873–878. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao RZ, Jiang S, Zhang L and Yu ZB:
Mitochondrial electron transport chain, ROS generation and
uncoupling (Review). Int J Mol Med. 44:3–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu L, Dong J, Wang L, Xia Q, Zhang D, Kim
H, Yin T, Fan S and Shen Q: Activation of STAT3 and Bcl-2 and
reduction of reactive oxygen species (ROS) promote radioresistance
in breast cancer and overcome of radioresistance with niclosamide.
Oncogene. 37:5292–5304. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Diwanji N and Bergmann A: An unexpected
friend-ROS in apoptosis-induced compensatory proliferation:
Implications for regeneration and cancer. Semin Cell Dev Biol.
80:74–82. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sun X, Jia H, Xu Q, Zhao C and Xu C:
Lycopene alleviates H2O2-induced oxidative stress, inflammation and
apoptosis in bovine mammary epithelial cells via the NFE2L2
signaling pathway. Food Funct. 10:6276–6285. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang Y, Yan J, Wang L, Dai H, Li N, Hu W
and Cai H: HIF-1α promotes breast cancer cell MCF-7 proliferation
and invasion through regulating miR-210. Cancer Biother Radiopharm.
32:297–301. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lai HH, Li JN, Wang MY, Huang HY, Croce
CM, Sun HL, Lyu YJ, Kang JW, Chiu CF, Hung MC, et al: HIF-1α
promotes autophagic proteolysis of Dicer and enhances tumor
metastasis. J Clin Invest. 128:625–643. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Sun RC, Board PG and Blackburn AC:
Targeting metabolism with arsenic trioxide and dichloroacetate in
breast cancer cells. Mol Cancer. 10(142)2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang MH, Zang YS, Huang H, Chen K, Li B,
Sun GY and Zhao XW: Arsenic trioxide exerts anti-lung cancer
activity by inhibiting angiogenesis. Curr Cancer Drug Targets.
14:557–566. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Han YH, Kim SH, Kim SZ and Park WH:
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung
cancer Calu-6 cells via the prevention of GSH depletion. Int J
Oncol. 5:1099–1105. 2008.PubMed/NCBI
|
|
26
|
Hsin IL, Ou CC, Wu TC, Jan MS, Wu MF, Chiu
LY, Lue KH and Ko JL: GMI, an immunomodulatory protein from
Ganoderma microsporum, induces autophagy in non-small cell lung
cancer cells. Autophagy. 7:873–882. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dueñas-González A and Campbell S: Global
strategies for the treatment of early-stage and advanced cervical
cancer. Curr Opin Obstet Gynecol. 28:11–17. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu H, Pei G, Song M, Dai S and Wang Y:
Influence of hsa-miR-6727-5p on the proliferation, apoptosis,
invasion and migration of Caski, Hela and SiHa cervical cancer
cells. J BUON. 22:973–978. 2017.PubMed/NCBI
|
|
30
|
Sakai C, Arai M, Tanaka S, Onda K,
Sugiyama K and Hirano T: Effects of arsenic compounds on growth,
cell-cycle distribution and apoptosis of tretinoin-resistant human
promyelocytic leukemia cells. Anticancer Res. 34:6489–6494.
2014.PubMed/NCBI
|
|
31
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Menderes G, Black J, Schwab CL and Santin
AD: Immunotherapy and targeted therapy for cervical cancer: An
update. Expert Rev Anticancer Ther. 16:83–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Geretto M, Pulliero A, Rosano C, Zhabayeva
D, Bersimbaev R and Izzotti A: Resistance to cancer
chemotherapeutic drugs is determined by pivotal microRNA
regulators. Am J Cancer Res. 7:1350–1371. 2017.PubMed/NCBI
|
|
34
|
Kuo YJ, Liu YJ, Way TD, Chiang SY, Lin JG
and Chung JG: Synergistic inhibition of leukemia WEHI-3 cell growth
by arsenic trioxide and Hedyotis diffusa Willd extract in
vitro and in vivo. Exp Ther Med. 13:3388–3396.
2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lunghi P, Giuliani N, Mazzera L, Lombardi
G, Ricca M, Corradi A, Cantoni AM, Salvatore L, Riccioni R,
Costanzo A, et al: Targeting MEK/MAPK signal transduction module
potentiates ATO-induced apoptosis in multiple myeloma cells through
multiple signaling pathways. Blood. 112:2450–2462. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sarkar S, Mukherjee S, Chattopadhyay A and
Bhattacharya S: Low dose of arsenic trioxide triggers oxidative
stress in zebrafish brain: Expression of antioxidant genes.
Ecotoxicol Environ Saf. 107:1–8. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Qu H, Tong D, Zhang Y, Kang K, Zhang Y,
Chen L and Ren L: The synergistic antitumor activity of arsenic
trioxide and vitamin K2 in HL-60 cells involves increased ROS
generation and regulation of the ROS-dependent MAPK signaling
pathway. Pharmazie. 68:839–845. 2013.PubMed/NCBI
|
|
38
|
Hassani S, Ghaffari SH, Zaker F, Mirzaee
R, Mardani H, Bashash D, Zekri A, Yousefi M, Zaghal A, Alimoghaddam
K and Ghavamzadeh A: Azidothymidine hinders arsenic
trioxide-induced apoptosis in acute promyelocytic leukemia cells by
induction of p21 and attenuation of G2/M arrest. Ann Hematol.
92:1207–1220. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pollak M: Targeting oxidative
phosphorylation: Why, when, and how. Cancer Cell. 23:263–264.
2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ and
Kim KW: Antitumor activity of arsenic trioxide on retinoblastoma:
Cell differentiation and apoptosis depending on arsenic trioxide
concentration. Invest Ophthalmol Vis Sci. 50:1819–1823.
2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chayapong J, Madhyastha H, Madhyastha R,
Nurrahmah QI, Nakajima Y, Choijookhuu N, Hishikawa Y and Maruyama
M: Arsenic trioxide induces ROS activity and DNA damage, leading to
G0/G1 extension in skin fibroblasts through the ATM-ATR-associated
Chk pathway. Environ Sci Pollut Res Int. 24:5316–5325.
2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Su W, Huang L, Ao Q, Zhang Q, Tian X, Fang
Y and Lu Y: Noscapine sensitizes chemoresistant ovarian cancer
cells to cisplatin through inhibition of HIF-1α. Cancer Lett.
350:94–99. 2011.PubMed/NCBI View Article : Google Scholar
|
